THE COST-EFFECTIVENESS OF PAIN TREATMENT - WHO CARES

被引：9
|
作者：
STIEG, RL
机构：
[1] COLORADO REHABIL INST, DEPT MED, DENVER, CO 80234 USA
[2] UNIV COLORADO, HLTH SCI CTR, DEPT NEUROL, DENVER, CO 80262 USA
来源：
CLINICAL JOURNAL OF PAIN | 1990年 / 6卷 / 04期
关键词：
COST-EFFECTIVENESS; DISABILITY; PAIN; TREATMENT;
D O I：
10.1097/00002508-199012000-00008
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Those in professions treating pain must prepare to justify the cost-effectiveness of the treatments they supply. Attempts have been made to define cost-effectiveness. Is it the lowest possible cost? The return of the patient to work and other daily activities? Pain clinics must develop good working relationships with business providers; establish credibility; plan, communicate, evaluate results scientifically; and educate the public.
引用
收藏
页码：301 / 304
页数：4
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF MIROGABALIN IN TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN MAINLAND CHINA
    He, Y.
    Dai, D.
    Vashi, R.
    Xu, H.
    Jin, M.
    Feng, Y.
    Yang, H.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S123 - S123
  • [32] Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment
    Cortesi, Paolo Angelo
    D'Angiolella, Lucia Sara
    Vellucci, Renato
    Allegri, Massimo
    Casale, Giuseppe
    Favaretti, Carlo
    Kheiraoui, Flavia
    Cesana, Giancarlo
    Mantovani, Lorenzo Giovanni
    [J]. PLOS ONE, 2017, 12 (06):
  • [33] Pregabalin vs gabapentin in the treatment of neuropathic pain in Italy: A cost-effectiveness analysis
    Pradelli, L.
    Marchettini, P.
    Iannazzo, S.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A375 - A375
  • [34] Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain
    Ruggeri, Matteo
    Turriziani, Adriana
    Oradei, Marco
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (03) : 459 - 464
  • [35] Efficacy, utility and cost-effectiveness of multidisciplinary treatment for chronic low back pain
    Salathe, C. Rolli
    Elfering, A.
    Melloh, M.
    [J]. SCHMERZ, 2012, 26 (02): : 131 - 149
  • [36] A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain
    Tyree, Griffin A.
    Sarkar, Reith
    Bellows, Brandon K.
    Ellis, Ronald J.
    Atkinson, Joseph Hampton
    Marcotte, Thomas D.
    Wallace, Mark S.
    Grant, Igor
    Shi, Yuyan
    Murphy, James D.
    Grelotti, David J.
    [J]. CANNABIS AND CANNABINOID RESEARCH, 2019, 4 (01) : 62 - 72
  • [37] Efficacy and cost-effectiveness: A study of different treatment approaches in a tertiary pain centre
    Vanhaudenhuyse, A.
    Gillet, A.
    Malaise, N.
    Salamun, I.
    Barsics, C.
    Grosdent, S.
    Maquet, D.
    Nyssen, A-S.
    Faymonville, M-E.
    [J]. EUROPEAN JOURNAL OF PAIN, 2015, 19 (10) : 1437 - 1446
  • [38] COST-EFFECTIVENESS ANALYSIS OF ORAL FENTANYL FORMULATIONS FOR BREAKTHROUGH CANCER PAIN TREATMENT
    D'Angiolella, L. S.
    Cortesi, P. A.
    Kheiraoui, F.
    Allegri, M.
    Casale, G.
    Vellucci, R.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A734 - A734
  • [39] Cost-effectiveness of troponins in patients with chest pain who are at low risk for myocardial infarction.
    Natarajan, S
    Kinosian, B
    [J]. MEDICAL DECISION MAKING, 1998, 18 (04) : 461 - 461
  • [40] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
12345